Those of you who have been around long enough will know just how long I have been posting on this thread... those who haven't just need to glance at my posting history to see.
It has been an arduous journey, ups and downs, hype and down ramping, opportunities and lost opportunities... all the emotions have emerged along the way. You name it... we have experienced it with VLA.
Finally we have received our long awaited takeover offer.
Then those emotions emerge once again.... initially, excitement, joy, relief, satisfaction.....
After the dust settles, the euphoria wears thin and we think more deeply about the situation.
The emotion is governed by our greed.... we believe the offer should have been higher... AND WE GOT SCREWED... the Board did a sh*t job.
Soon posters will be declaring war on the Board and insisting we stand united and vote vigorously against the proposal... because clearly, manipulation/self interests/ conspiracy have been at play.... AND WE GOT SCREWED.
We will read where the offer should have been $500million for EACH cancer type.... PROVING WE GOT SCREWED.
So how about we take a few deep breaths, sit back, put our minds in neutral and ponder a few salient points......
How do each of you decide the value of VLA?.... are you skilled in this area?
And please don't say something like.... "well, XYZ Pharma paid a lot more for a lesser minnow than VLA"
Really, what were the circumstances involved in that deal?... different Company/different product/ fits predator's business.
Its like saying..... "I should have got more for my lemons than you did for your potatoes."
Personally I have no idea how a Pharma values a product in Phase 2 Clinical Trials.... bearing in mind the ensuing risks.
The value of anything is "what someone will pay for it".
So far, someone is prepared to pay $1.75 per share for VLA.
If someone else decides that represents grand larceny.... if it suits them... they will submit a higher offer.
There is plenty of time for that to happen. If it does, then the Board have done the right thing in initiating the process.
If it doesn't happen, the Bio world has decided their is no benefit in offerring more.... and the Board, again, has done the right thing.
The offer is $500million UP FRONT!.... no waiting for milestones.
You can go ahead and make plans... you can sell some/all now and re-invest elsewhere... you have flexibility and opportunity.
Better than placing too high a price on your product... not attracting a bid.... and being left with your decaying potatoes.
I remember posting months ago..... "we are now amidst a smorgasbord of products in the Biosphere and if an offer is not forthcoming soon, we may become last year's flavour"
Lastly, in real terms.... compare your circumstances:- You are reaping rewards from the sale of a Company involved with curing cancer patients. You are not happy.
Ponder what would make the cancer patients happy.
Expand
